Shareholders approve 2024 Equity Incentive Plan adding 2.1M shares; all director nominees elected

Astrana Health, Inc.

All nine director nominees elected at June 12 annual meeting; quorum of 75.6%.
2024 Equity Incentive Plan approved (37.1M for); authorizes 2.1M new shares, replacing 2015 Plan.
Advisory 'say-on-pay' passed (37.3M for); Ernst & Young ratified as auditor for FY 2024.
Charter amendment adding officer exculpation provisions approved.
Plan effective Feb 28, 2024; no changes to executive compensation or board composition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.